FAM96A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.666200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.402200E-02
Normal-vs-Stage2
3.783900E-02
Normal-vs-Stage3
5.200900E-03
Normal-vs-Stage4
5.584400E-02
Stage1-vs-Stage2
4.075200E-01
Stage1-vs-Stage3
1.574070E-02
Stage1-vs-Stage4
1.628840E-01
Stage2-vs-Stage3
7.670300E-02
Stage2-vs-Stage4
3.501800E-01
Stage3-vs-Stage4
5.512600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.432000E-02
Normal-vs-AfricanAmerican
7.562500E-03
Normal-vs-Asian
2.076600E-01
Caucasian-vs-AfricanAmerican
9.676800E-01
Caucasian-vs-Asian
8.770800E-01
AfricanAmerican-vs-Asian
9.117000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.238490E-02
Normal-vs-Female
6.254400E-02
Male-vs-Female
1.304230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.635800E-01
Normal-vs-Age(41-60Yrs)
3.470100E-02
Normal-vs-Age(61-80Yrs)
2.378300E-02
Normal-vs-Age(81-100Yrs)
6.810400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.957000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.058000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.935600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.004400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.358200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.617600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.487900E-02
Normal-vs-Daily Drinker
2.664400E-02
Normal-vs-Weekly Drinker
1.282400E-01
Normal-vs-Occasional Drinker
3.659100E-03
Normal-vs-Social Drinker
9.215800E-03
Non Drinker-vs-Daily Drinker
6.134600E-01
Non Drinker-vs-Weekly Drinker
6.125200E-01
Non Drinker-vs-Occasional Drinker
4.586400E-01
Non Drinker-vs-Social Drinker
3.265800E-01
Daily Drinker-vs-Weekly Drinker
8.956000E-01
Daily Drinker-vs-Occasional Drinker
8.113000E-01
Daily Drinker-vs-Social Drinker
5.875600E-01
Weekly Drinker-vs-Occasional Drinker
9.769800E-01
Weekly Drinker-vs-Social Drinker
7.952800E-01
Occasional Drinker-vs-Social Drinker
7.087400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.607400E-01
Normal-vs-Grade 2
9.718000E-01
Normal-vs-Grade 3
9.823200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.760000E-01
Grade 1-vs-Grade 3
6.569200E-01
Grade 1-vs-Grade 4
9.607400E-01
Grade 2-vs-Grade 3
7.603400E-01
Grade 2-vs-Grade 4
9.718000E-01
Grade 3-vs-Grade 4
9.823200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.340000E-03
Normal-vs-NonDiabetic
3.082400E-02
Diabetic-vs-NonDiabetic
1.024620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.551700E-02
Normal-vs-NoPancreatitis
2.651900E-02
Pancreatitis-vs-NoPancreatitis
7.913800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.562400E-03
Normal-vs-N1
4.352200E-02
N0-vs-N1
6.021600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.407580E-01
Normal-vs-TP53-NonMutant
5.940000E-02
TP53-Mutant-vs-TP53-NonMutant
1.891010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
